CTLA4 and neoplasm: According to one study, anti-CTLA-4 antibody therapy improved the prognosis of mice with glycolysis-deficient tumors, indicating that decreased tumor competition for glucose may enhance the therapeutic effect of CTLA-4 blockers [40].